{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:07:37Z","timestamp":1791594457565,"version":"4.3.4"},"reference-count":43,"publisher":"Baishideng Publishing Group Inc.","issue":"44","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2014]]},"DOI":"10.3748\/wjg.v20.i44.16529","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T03:21:44Z","timestamp":1417490504000},"page":"16529","source":"Crossref","is-referenced-by-count":66,"title":["Drug induced acute pancreatitis: Does it exist?"],"prefix":"10.3748","volume":"20","author":[{"given":"Scott","family":"Tenner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"van Brummelen SE, Venneman NG, van Erpecum KJ, VanBerge-Henegouwen GP. Acute idiopathic pancreatitis: does it really exist or is it a myth? Scand J Gastroenterol Suppl 2003;117-122.","DOI":"10.1080\/008559203100027"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60107-5"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.1007"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.430"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/00006676-200308000-00001"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.218"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31818f9227"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-010-1367-2"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.11.023"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1987.tb03011.x"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Tenner S. Isotretinoin and inflammatory bowel disease: trial lawyer misuse of science and FDA warnings. Am J Gastroenterol 2014;109:570-571.","DOI":"10.1038\/ajg.2014.34"},{"key":"ref12","unstructured":"Federal Food, Drug , and Cosmetic Act, 21 U. S.C.A. 301-399f (West 2013). Available from: http:\/\/web2.westlaw.com\/signon\/default.wl?vr=2.0&fn=_top&rs=WLW14.10&bhcp=1<\/ext-link>."},{"key":"ref13","unstructured":"Irey NS. Diagnostic problems in drug-induced diseases. Ann Clin Lab Sci 1976;6:272-277."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.329.7456.44"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.286.6363.458"},{"key":"ref16","unstructured":"Available from: http:\/\/www.fda.gov\/Safety\/MedWatch\/default.htm<\/ext-link>."},{"key":"ref17","unstructured":"Struve CT. The FDA and the tort system: postmarketing surveillance, compensation, and the role of litigation. Yale J Health Policy Law Ethics 2005;5:587-669."},{"key":"ref18","unstructured":"Food and Drug Administration Amendments Act of 2007, PL 110–85, September 27, 2007, 121 Stat. 823. Available from: http:\/\/web2.westlaw.com\/signon\/default.wl?vr=2.0&fn=_top&rs=WLW14.10&bhcp=1<\/ext-link>."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.29.02.06.dc05-2043"},{"key":"ref20","unstructured":"Drug Evaluation and Research. Division Director’s Memo, Pancreatitis (June 18, 2009). Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2009\/021919s000SumR.pdf at 13<\/ext-link>."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2010.01231.x"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200204000-00018"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P714a"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.02.018"},{"key":"ref25","unstructured":"Available from: http:\/\/newsroom.lilly.com\/releasedetail.cfm?releaseid=462639<\/ext-link>."},{"key":"ref26","unstructured":"FDA , Amylin Pharmaceuticals, Inc . , Bydureon, Highlights of Prescribing Information (Jan 2012). Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/022200s000lbl.pdf at 5, 12, 27<\/ext-link>."},{"key":"ref27","unstructured":"Complaint for Damages, Johnson v. Amylin Pharmaceuticals, 13CV1346 DMS NLS (S.D. Cal. filed June 10, 2013). Available from: http:\/\/web2.westlaw.com\/signon\/default.wl?vr=2.0&fn=_top&rs=WLW14.10&bhcp=1<\/ext-link>."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1314078"},{"key":"ref29","unstructured":"Weed DL, Gorelic LS. The practice of causal inference in cancer epidemiology. Cancer Epidemiol Biomarkers Prev 1996;5:303-311."},{"key":"ref30","unstructured":"Weed DL. Causal and Preventive Inference. Cancer Prevention and Control. Chapter 17 New York: Marcel Dekker; 1995;285-302."},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.","DOI":"10.1177\/003591576505800503"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(98)80007-6"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03412.x"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07459.x"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS. Treatment of Crohn’s disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med 1980;302:981-987.","DOI":"10.1056\/NEJM198005013021801"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Haber CJ, Meltzer SJ, Present DH, Korelitz BI. Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease. Gastroenterology 1986;91:982-986.","DOI":"10.1016\/0016-5085(86)90703-1"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.307"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Mallory A, Kern F. Drug-induced pancreatitis: a critical review. Gastroenterology 1980;78:813-820.","DOI":"10.1016\/0016-5085(80)90689-7"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-009-0016-4"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199005103221901"},{"key":"ref41","unstructured":"Maxson CJ, Greenfield SM, Turner JL. Acute pancreatitis as a common complication of 2’,3’-dideoxyinosine therapy in the acquired immunodeficiency syndrome. Am J Gastroenterol 1992;87:708-713."},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1307684"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2012.09.008"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v20\/i44\/16529.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T01:28:14Z","timestamp":1566091694000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v20\/i44\/16529.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":43,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v20.i44.16529","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}